Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Healthcare
Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

Recent & Breaking News (TSXV:CLAS.H)

IIROC Trading Halt - KLY

Canada NewsWire May 13, 2020

Kalytera Announces Updates to Its Annual and Interim Filings

GlobeNewswire April 28, 2020

The StockTalk Cannabis Report: Apr 24, 2020. 4/20 Meets COVID-19

Dave Jackson April 24, 2020

Kalytera and Stero Biotechs Will Not Proceed with Acquisition

GlobeNewswire April 13, 2020

The StockTalk Cannabis Report: Mar 27, 2020.

Dave Jackson March 27, 2020

The StockTalk Cannabis Report: Mar 20, 2020. In the Green Again.

Dave Jackson March 20, 2020

Kalytera Provides Additional Detail Regarding Terms of Stero Biotechs, Ltd. Acquisition

GlobeNewswire March 18, 2020

Kalytera Announces Extension of Maturity Date of Promissory Note

GlobeNewswire March 16, 2020

The StockTalk Cannabis Report: Mar 13, 2020. Keep Calm and Carry On Edition.

Dave Jackson March 13, 2020

IIROC Trading Resumption - KLY

Canada NewsWire March 9, 2020

IIROC Trading Halt - KLY

Canada NewsWire March 6, 2020

IIROC Trading Resumption - KLY

Canada NewsWire March 6, 2020

The StockTalk Cannabis Report: Mar 6, 2020

Dave Jackson March 6, 2020

Kalytera Announces Trading Halt

GlobeNewswire March 5, 2020

IIROC Trading Halt - KLY

Canada NewsWire March 5, 2020

Kalytera to Acquire Stero Biotechs, Ltd.

GlobeNewswire March 5, 2020

The Top Cannabis Bullboards: Jan - Feb 2020

Stockhouse Editorial March 3, 2020

The StockTalk Cannabis Report: Feb 28, 2020

Dave Jackson February 28, 2020

Kalytera Announces Modification to Sale Period for Shares Issued under Payments Agreement

GlobeNewswire February 19, 2020

The StockTalk Cannabis Report: Feb 14, 2020

Dave Jackson February 14, 2020